A61K 31/6615
Compounds having two or more esterified phosphorus acid groups
Official title: Compounds having two or more esterified phosphorus acid groups, e.g. inositol triphosphate, phytic acid
A61K31/6615 (Compounds having two or more esterified phosphorus acid groups) appears on 219 US grants and 428 published applications in this corpus.
Search patents in A61K- Granted patents
- 219
- Published applications
- 428
- Assignees
- 219
- Inventors
- 689
- Latest grant
- 15 Sep 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1993 | 1 | 0 |
| 1994 | 0 | 0 |
| 1995 | 1 | 0 |
| 1996 | 0 | 0 |
| 1997 | 2 | 0 |
| 1998 | 2 | 0 |
| 1999 | 3 | 0 |
| 2000 | 2 | 0 |
| 2001 | 3 | 0 |
| 2002 | 3 | 7 |
| 2003 | 3 | 3 |
| 2004 | 0 | 12 |
| 2005 | 3 | 9 |
| 2006 | 3 | 11 |
| 2007 | 0 | 9 |
| 2008 | 2 | 10 |
| 2009 | 1 | 20 |
| 2010 | 9 | 16 |
| 2011 | 11 | 14 |
| 2012 | 9 | 17 |
| 2013 | 9 | 17 |
| 2014 | 9 | 26 |
| 2015 | 15 | 18 |
| 2016 | 13 | 25 |
| 2017 | 11 | 32 |
| 2018 | 20 | 18 |
| 2019 | 11 | 21 |
| 2020 | 7 | 16 |
| 2021 | 12 | 25 |
| 2022 | 14 | 29 |
| 2023 | 13 | 27 |
| 2024 | 12 | 19 |
| 2025 | 10 | 15 |
| 2026 | 5 | 12 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Recent patents
- Clinical dosing schedule of inositol phosphate oligo(ethylene glycol) compounds15 Sep 2026US 12,734,184 B2Vifor (International) AG
- Topical antiviral compositions comprising hyaluronic acid and carrageenan2 Jun 2026US 12,642,814 B2Ricerfarma S.R.L.
- IP and IP analogs dosage regimens for the treatment of ectopic calcifications7 Apr 2026US 12,594,290 B2Sanifit Therapeutics S.A.
- Compositions and methods for hair follicle regeneration24 Mar 2026US 12,582,649 B2Washington University
- Compositions for clinical complications associated to devices implanted in the urinary tract24 Feb 2026US 12,558,363 B2Devicare SL
- Novel phosphate compounds and process for preparation thereof17 Sep 2026US 2026/0272959 A1
- Inositol phosphate compounds for use in increasing tissular perfusion20 Aug 2026US 2026/0240877 A1
- Ether of phosphatidylcholine and phosphatidylethanolamine, their lyso-forms and mixture thereof for use in the treatment of a disease or disorder caused by a deficiency in plasmalogens30 Jul 2026US 2026/0217743 A1Baker Heart and Diabetes Institute
- Combinations treatments2 Jul 2026US 2026/0182577 A1Aequor, Inc.
- Abcb5 ligands and substrates2 Jul 2026US 2026/0184810 A1Children's Medical Center Corporation
Most cited
By later US patents
- Crystallization method and bioavailability84US 9,169,279 B2Thar Pharmaceuticals, Inc. · 2015
- Natural marine source phospholipids comprising polyunsaturated fatty acids and their applications66US 8,030,348 B2Neptune Technologies & Bioressources, Inc. · 2011
- Modulation of glycolytic ATP production55US 5,707,971 ALife Resuscitation Technologies, Inc. · 1998
- Methods for treating Filoviridae virus infections51US 9,724,360 B2Gilead Sciences, Inc. · 2017
- Methods for treating Filoviridae virus infections45US 9,949,994 B2Gilead Sciences, Inc. · 2018